The role of chemotherapy in cholangiocarcinoma
Author:
- 1 June 2005
- journal article
- review article
- Published by Elsevier in Annals of Oncology
- Vol. 16 (suppl_2) , ii93-ii96
Abstract
S. Thongprasert; The role of chemotherapy in cholangiocarcinoma, Annals of Oncology, Volume 16, Issue suppl_2, 1 June 2005, Pages ii93–ii96, https://doi.org/10Keywords
This publication has 30 references indexed in Scilit:
- Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinomaAnnals of Oncology, 2005
- Gemcitabine, 5‐fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinomaCancer, 2004
- Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR studyAnnals of Oncology, 2004
- Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinomaCancer, 2004
- Epirubicin, cisplatin, and protracted infusion of 5-FU (ECF) in advanced intrahepatic cholangiocarcinomaJournal of Cancer Research and Clinical Oncology, 2004
- Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced biliary cancerAnnals of Oncology, 2003
- Effects of 5-Fluorouracil and Leucovorin in the Treatment of Pancreatic–Biliary Tract AdenocarcinomasAmerican Journal of Clinical Oncology, 2000
- Gemcitabine for the Treatment of Advanced Biliary Tract Carcinomas: Evaluation of Two Different Dose RegimensOncology Research and Treatment, 1999
- Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumoursEuropean Journal of Cancer, 1995
- Comparison of 5-Fluorouracil, Doxorubicin and Mitomycin C with 5-Fluorouracil Alone in the Treatment of Pancreatic-Biliary CarcinomasOncology, 1994